Category: News Well
Content tagged to appear in the middle column of the home page
AngioDynamics names Joseph DeVivo as its new CEO, replacing Jan Keltjens, and reveals the departure of one of its senior business development executives.
AngioDynamics Inc. (NSDQ:ANGO) named a replacement for former CEO Jan Keltjens, who left suddenly in June, tapping Joseph DeVivo for the corner office.
The Latham, N.Y.-based oncology device company also revealed the resignation of senior vice president of business development Lynda Wallace, according to SEC filings.
Medical device giant Medtronic announces CE Mark approval in the European Union and imminent commercial launch of its Export Advance thrombus removal system.
Medical device industry titan Medtronic (NYSE:MDT) announced today that it won CE Mark approval in the European Union for its latest thrombus removal system, the Export Advance aspiration catheter.
The new device, the latest in the Export family, will hit the shelves "soon" in Europe and other international markets, Medtronic reported.
The millions of dollars in fees that medical device companies pay for FDA review aren't exempt from sequestration, meaning the agency may lack the resources to keep up with promises that it made to the industry in exchange for the funds.
The federal sequester is siphoning away part of the funds that the medical device industry is paying for FDA review of new technologies, and that means the agency may not be able to keep all the promises it made in exchange for hiking its user fees.
EnteroMedics expects to file for pre-market approval from the FDA this quarter for its Maestro vagal nerve blocking weight loss device.
EnteroMedics (NSDQ:ETRM) said it expects to submit a pre-market approval application to the FDA this quarter for its Maestro rechargeable vagal blocking therapy to treat obesity.
The U.S. Supreme Court agrees to hear Medtronic's appeal of a patent infringement loss to rival Boston Scientific over cardiac rhythm management technology.
Natus Medical beats Wall Street's earnings forecast with a 1,000-fold profit surge on record sales, prompting the medical device company to raise its earnings forecast for the rest of the year.
Natus Medical (NSDQ:BABY) reported a 1,000% increase in profits during the 1st quarter, handily beating Wall Street's earnings-per-share forecast in the process.
The New York Times lists the 10 most expensive hospitals in the United States, based on CMS data
MASSDEVICE ON CALL — Bayonne Medical Center in Bayonne, N.J., billed Medicare an average of 4 times higher than the national average for the 100 most common procedures, according to the New York Times.